The Familial Hypercholesterolemia Foundation

The VESALIUS-REAL study of 278,000 high-risk patients found 70% did not receive lipid-lowering therapy after heart attacks or strokes, and 88% had no treatment intensification within a year.

A landmark study of over 273,000 individuals with atherosclerotic cardiovascular disease found that every increase in lipoprotein(a) levels is associated with higher risk of recurrent cardiovascular events.

The Family Heart Foundation has introduced Cholesterol Connect, offering free at-home lipid screening and personalized support to address cardiovascular disease, which claims one American life every 33 seconds.